As lending markets get tighter and the only certain thing on the horizon is uncertainty, advisers are sharpening their pencils to put a value on businesses. In this month’s cover story David Prosser looks at how sellers and buyers strike a price. Pharma, medical and biotech M&A is in the spotlight and we look at deals and the corporate finance network in the South West. We also profile the senior corporate finance professionals who became members of the faculty board this summer.
News and views
This year’s Annual Reception, the new ‘Earn-outs in Deals’ guideline, and the Future of UK Capital Markets Regulation Summit.Read more
Jon Moulton on pensions and PE
Will recent pledges from pension funds to allocate cash to private equity achieve anything, asks Jon Moulton.Read more
Innovation and sustainable recovery
Future advisory professionals
Corporate Finance Faculty Board
This year, the Corporate Finance Faculty welcomed a new chair and eight new board members. Meet them here.Read more
on my cv
If expectations are not initially met, be patient and address buyer value issues before re-engaging, is the advice from Mark Wilson of Headpoint.Read more
Steps to Europe
Hana Bell arrived from Canada in 2020 to COVID-19 controls and hiring freezes, waiting a year to join Simmons & Simmons corporate law team.Read more
Browse Corporate Financier content from July/August 2023 and earlier.